Furthermore, higher plasma pro-inflammatory markers sTNF-R1 and CHI3L1, lipid metabolic abnormalities, sarcopenia, and risk of tumor recurrence were found to be concurrently associated based on multi-omics studies examining the main pathways connecting sarcopenia and liver cancer. This evidence concerns the gene CHI3L1 and liver cancer.